Related by context. All words. (Click for frequent words.) 61 Slatore 61 Mofenson 61 Sackner Bernstein 60 Kantarjian 60 Boden Albala 60 Shlipak 59 Mayo Clinic hematologist 59 Cristofanilli 59 perioperatively 59 thromboembolic disease 59 undergoing peritoneal dialysis 59 Trasande 59 Kalantar Zadeh 59 surgically resectable 59 Ascherio 59 cranial irradiation 59 Kotloff 59 transferrin saturation 59 β blockers 59 selenium supplementation 59 gastro oesophageal reflux disease 58 Adjuvant chemotherapy 58 Joshua Schier 58 Di Bisceglie 58 Soffritti 58 Bresalier 58 Polycythemia vera 58 Montalescot 58 Shekelle 58 Uncontrolled hypertension 58 lichen planus 57 immunomodulatory agents 57 Adjuvant therapy 57 Amarenco 57 Kaklamani 57 thalidomide Thalomid 57 postoperative pulmonary 57 Gheorghiade 57 poststroke depression 57 mitochondrial toxicity 57 Grothey 57 Steven Galson MD MPH 57 El Deiry 57 Oparil 57 COPD exacerbations 57 recurrent glioblastoma multiforme 57 thrombotic complications 57 temporal arteritis 57 metastatic uveal melanoma 57 Dr. Yair Lotan 57 Baggish 56 FASLODEX 56 Belldegrun 56 beta blocker therapy 56 Pi Sunyer 56 gastro oesophageal reflux 56 immunosuppressive therapies 56 Jackevicius 56 MD DPhil 56 induced hepatotoxicity 56 infliximab Remicade 56 Amir Lerman 56 Oeffinger 56 Proteinuria 56 Abram Hoffer 56 Nordestgaard 56 Neugut 56 Mayo Clinic rheumatologist 56 BEXXAR Therapeutic Regimen 56 cardiovascular morbidity 56 MD D.Phil 56 Aprotinin 56 rosiglitazone Avandia 56 atherosclerotic vascular disease 56 prostate cancer CaP 56 antiinflammatory drugs 56 Stopeck 56 urinary calcium 56 Schernhammer 56 beta carotene supplementation 56 efalizumab 56 asymptomatic hyperuricemia 56 CLINICAL PHARMACOLOGY 56 Hesdorffer 56 Zivadinov 56 squamous cell lung cancer 56 Myfortic 56 differentiated thyroid 56 hypercalciuria 55 conjugated estrogen 55 antiangiogenic therapy 55 Navas Acien 55 histological subtype 55 haematologic 55 lipid abnormalities 55 palliative radiotherapy 55 SGPT 55 chromium supplementation 55 hepatorenal syndrome 55 Fillit 55 Katz MD MPH 55 MD D.Sc. 55 developmental neurotoxicity 55 Laheru 55 NATRECOR ® 55 hematologic parameters 55 Cardiopulmonary bypass 55 renal toxicity 55 Estrogen Receptor 55 Pisters 55 fulvestrant 55 endometrial hyperplasia 55 breast endometrial 55 Chronic lymphocytic leukemia 55 metastatic lung cancer 55 chronic thromboembolic pulmonary 55 AVANDIA 55 autosomal dominant polycystic kidney 55 Paavonen 55 Durado Brooks 55 Kidney Disease Outcomes 55 serum GGT 55 valvular heart 55 CTEPH 55 Leitzmann 55 metastatic malignant 55 antifibrinolytic 55 Platinol ® 55 Bergenstal 55 Van Den Eeden 55 Miklowitz 55 macrovascular events 55 Wayne Katon 55 aldosterone antagonist 55 HIV HCV coinfected 55 Subgroup analyzes 55 Ancoli Israel 55 Muntner 55 Braunwald 55 sorafenib Nexavar 55 Avandia Actos 55 BENICAR HCT 55 LaPook 55 Bakris 55 intensive statin therapy 55 prolongs survival 55 Carotid Revascularization Endarterectomy vs. 55 MD tells WebMD 55 Schuckit 55 Relapsing remitting MS 55 antioxidant supplementation 55 mycophenolate mofetil 55 Buyyounouski 55 Jorge Cortes MD 55 hepatic toxicity 55 antibiotic prophylaxis 55 intact parathyroid hormone 55 Subgroup analysis 55 Michael Lincoff 55 anticholinergic agents 55 Medscape Oncology 54 pulmonary toxicity 54 Verstovsek 54 Bevacizumab Avastin 54 primary aldosteronism 54 Pochapin 54 Goldbach Mansky 54 Heavy menstrual bleeding 54 Winkelmayer 54 glomerular filtration 54 Helicobacter pylori infection 54 mycophenolic acid 54 Observational studies 54 benign biliary strictures 54 acid suppressive therapy 54 Vlachopoulos 54 statins cholesterol lowering 54 NCCN guidelines 54 gadobutrol 54 renoprotective 54 Len Lichtenfeld 54 ATACAND 54 pulmonary exacerbations 54 torsade de pointes 54 Pischon 54 eosinophilic pneumonia 54 Dermatol 54 Hashimoto thyroiditis 54 Calcium intake 54 non hodgkin lymphoma 54 polyp recurrence 54 gene polymorphism 54 Acute Liver Failure 54 Dr. Kauvar 54 diabetic kidney 54 Iris Loew Friedrich 54 Leffell 54 antihypertensive therapy 54 Piccart Gebhart 54 Mayo Clinic gastroenterologist 54 pentoxifylline 54 fluvastatin 54 Wischik 54 Breteler 54 ImmuKnow assay 54 colorectal adenoma 54 Dr. Zelenetz 54 clinically insignificant 54 preoperative chemotherapy 54 S. Aureus 54 Sudhir Agrawal D.Phil 54 Azathioprine 54 symptomatic VTE 54 antiarrhythmic medications 54 GnRH agonists 54 Serebruany 54 metachronous 54 radioimmunotherapy RIT 54 immunosuppressive regimen 54 Farkouh 54 Gurbel 54 ruboxistaurin 54 Spironolactone 54 bullous 54 STRIDE PD 54 Zamvil 54 Schatzkin 54 BRCA mutation carriers 54 valacyclovir Valtrex 54 Dr. Henschke 54 Am J Cardiol 54 Cremophor 54 Ruschitzka 54 esophageal reflux 54 liposomal amphotericin B 54 Cerhan 54 Renal dysfunction 54 localized prostate 54 hypervascular tumors 54 pancreatic adenocarcinoma 54 erlotinib Tarceva 54 leukoencephalopathy 54 danazol 54 coagulation abnormalities 54 paricalcitol 54 hematopoietic cancers 54 Pemetrexed 54 Schilsky 54 Plasma concentrations 54 adrenal suppression 54 malignant ascites 54 colorectal liver metastases 54 testosterone supplementation 54 MD FASGE 54 Richard Schilsky 54 primary hyperparathyroidism 54 airway hyperresponsiveness 54 Cooperberg 54 pulmonary fungal infections 54 vascular reactivity 53 neoadjuvant treatment 53 precancerous condition 53 Glycation 53 Bairey Merz 53 hypovitaminosis D 53 Gluud 53 myeloproliferative disorders 53 Moghissi 53 cutaneous lupus 53 Beall Ph.D. 53 oral clodronate 53 urinary oxalate 53 MD ScM 53 Strauss Noven 53 cutaneous melanoma 53 KRAS status 53 Candidiasis 53 cytoreductive surgery 53 minimally symptomatic 53 uridine triacetate 53 bronchopulmonary dysplasia 53 Weinstock Guttman 53 Zarnestra 53 serum phosphate 53 Natalizumab 53 Losina 53 Hydroxyurea 53 spontaneous regression 53 Glioblastoma Multiforme 53 Rachel Ballard Barbash 53 serum vitamin D 53 preserved ejection fraction 53 morphometric vertebral fractures 53 node metastases 53 glycated hemoglobin levels 53 follicular adenoma 53 Boffetta 53 aromatase inhibitors AIs 53 Bibbins Domingo 53 Tsimikas 53 recurrent venous thromboembolism 53 newer atypical antipsychotics 53 FDA Adverse Event 53 Atrophic 53 antioxidant vitamin supplements 53 pain palliation 53 Kantoff 53 chronic leukemias 53 hypereosinophilic syndrome 53 Toxicities 53 Cytoxan 53 abacavir lamivudine 53 Non inferiority 53 MD DrPH 53 pyridostigmine 53 Tashkin 53 Sprycel dasatinib 53 atopic disease 53 candidemia 53 Nonalcoholic fatty liver 53 Candida infections 53 asthma exacerbations 53 Venous thromboembolism 53 Nigrovic 53 pravastatin Pravachol 53 AST ALT 53 cervical carcinoma 53 Neuro Oncology Program 53 Bjelakovic 53 abacavir Ziagen 53 Anselmetti 53 metastatic GIST 53 urothelial cancer 53 Tschöp 53 plasma lipoprotein 53 piroxicam 53 Graft Versus Host 53 dual endothelin receptor antagonist 53 creatine supplementation 53 AA Amyloidosis 53 #-# Full Text 53 diabetes mellitus DM 53 Myelofibrosis 53 Stanley Fahn 53 Oral corticosteroids 53 Candida infection 53 Magnesium deficiency 53 statin medications 53 meta regression 53 SIADH 53 Olanow 53 clinicopathological 53 Kritchevsky 53 Stolzenberg Solomon 53 adjuvant radiotherapy 53 G6PD deficiency 53 Skehel 53 haloperidol Haldol 53 Poordad 53 metastatic gastric 53 Response Evaluation Criteria 53 Tlsty 53 rhinovirus infection 53 DAPT 53 postprandial glycemia 53 adalimumab Humira 53 Colin Baigent 53 Vidaza azacitidine 53 Mitchell Krucoff 53 Dobnig 53 endocrinologic 53 Aggrastat ® tirofiban hydrochloride 53 NEJM editorial 53 Hassenbusch 53 PCNSL 53 renal carcinoma 53 CMV infections 53 Shelley Salpeter 53 CYP #D# 53 Tardive dyskinesia 52 Microalbuminuria 52 Juurlink 52 MD FACC FAHA 52 Sharlip 52 Fondaparinux 52 Dangour 52 secondary amenorrhea 52 Phurrough 52 papillary renal cell carcinoma 52 cystoid macular edema 52 Tuomilehto 52 Brant Zawadzki 52 hepatotoxicity 52 hepatotoxic 52 arterial hypertension 52 Bengt Winblad 52 Fred Kavalier 52 rFVIIa 52 Vincent Cogliano 52 metastatic pancreatic 52 J. Clin 52 serum calcium 52 neoplastic 52 Martha L. Daviglus 52 locoregional 52 QTc intervals 52 Nonalcoholic Fatty Liver Disease 52 antitumor effect 52 invasive aspergillosis 52 Rabeneck 52 Wakelee 52 myelogenous leukemia 52 Le Prell 52 MD FRCP 52 Seewaldt 52 psoriatic arthritis PsA 52 gastrointestinal stromal tumor 52 Steinhubl 52 autoimmune pancreatitis 52 Meschia 52 Mayo Clinic oncologist 52 vascular thrombosis 52 radioiodine therapy 52 thyrotropin 52 cryptogenic 52 Certolizumab pegol 52 neurodevelopmental outcome 52 Paffenbarger 52 amyloid deposition 52 homocysteine concentrations 52 neoadjuvant therapy 52 Femara letrozole 52 somatostatin analogs 52 FUSILEV enhances 52 inversely associated 52 adjuvant therapies 52 serum triglycerides 52 mild renal insufficiency 52 cancerous colon polyps 52 potassium sparing diuretics 52 dermatologic reactions 52 androgen ablation 52 Joy Melnikow 52 PNH patients 52 5-fluorouracil/leucovorin 52 prospective multicentre 52 Elacytarabine 52 Dr. Zincke 52 antiplatelet drugs 52 pretransplant 52 Amy Abernethy 52 Androgen deprivation therapy 52 DeKosky 52 lymphocyte activation 52 ORWH 52 Vandetanib 52 ALI ARDS 52 oral anticoagulant therapy 52 subgroup analyzes 52 CP CPPS 52 lipid lowering therapies 52 Shoelson 52 dietary modification 52 membranous nephropathy 52 Waldenstrom 52 gastrointestinal stromal tumor GIST 52 Eric Kossoff 52 biliary stones 52 Subclinical 52 Genkinger 52 Mainous 52 TNF blocker therapy 52 hemorrhagic colitis 52 Dentali 52 ocular toxicity 52 Merikangas 52 nitrofurantoin 52 Nesiritide 52 MD FACG 52 multimodality therapy 52 Littrup 52 dexrazoxane 52 penicillin allergy 52 Squamous cell 52 RE LY trial 52 Mozaffarian 52 intracerebral haemorrhage 52 TNF therapy 52 liver metastasis 52 QTc interval 52 Staessen 52 postoperative mortality 52 Kattlove 52 neurocognitive function 52 angiogenesis inhibition 52 El Sohemy 52 carotid IMT 52 diabetic polyneuropathy 52 gastric adenocarcinoma 52 leflunomide 52 BENICAR 52 adenoma recurrence 52 MD Sc.D. 52 strontium ranelate 52 Warach 52 venous thromboembolic disease 52 Chimowitz 52 Nephrogenic 52 C. trachomatis 52 symptomatic intracranial 52 fluoride ingestion 52 mycophenolate 52 antiarrhythmic drug 52 Ezekowitz 52 pioglitazone Actos 52 See CLINICAL PHARMACOLOGY 52 systemic mastocytosis 52 standard chemotherapy regimen 52 nephrotoxicity 52 lenalidomide Revlimid 52 Ben Slotman 52 severe asthma exacerbations 52 metastatic bone 52 zoledronate 52 Hypotension 52 nonsteroidal antiinflammatory drugs 52 acetaminophen toxicity 52 cystic fibrosis chronic pancreatitis 52 de las Fuentes 52 resistant hormone refractory 52 inflammatory biomarkers 52 CMV disease 52 Chavarro 52 Lipshultz 52 Adesman 52 Farzaneh Far 52 Glioblastoma Multiforme GBM 52 thrombotic events 52 Guallar 52 bezafibrate 52 Basal Cell 52 Arch Intern Med 52 Gangwisch 52 EGFRIs 52 ADPKD 52 superficial bladder cancer 52 Muraglitazar 52 Matchar 52 unmeasured confounders 52 MYLOTARG 52 Agus MD 52 Urken 52 Pseudomonas aeruginosa infections 52 pharmacologic intervention 52 contrast induced nephropathy 52 Lavonas 52 alkylating agent 52 cardiovascular mortality 51 bone scintigraphy 51 Barbaresi 51 GVAX Pancreas Vaccine 51 SIMCOR 51 heterozygous FH 51 hemorrhagic complications 51 MD Ph.D. Kosan 51 mRCC 51 adjuvant systemic 51 Patricia Hartge 51 prognostic significance 51 Overdiagnosis 51 cholangiocarcinoma 51 Chronic Bronchitis 51 Ian Fentiman 51 ximelagatran 51 TNF antagonist 51 malabsorptive 51 mayoclinic.com 51 palifermin 51 neuroleptic 51 Severe Asthma 51 chemoradiation therapy 51 platelet inhibitor 51 recurrent metastatic 51 ischemic cardiomyopathy 51 Dr. Parungao 51 Wolmark 51 androgen deprivation 51 advanced epithelial ovarian 51 HER2 expression 51 residual confounding 51 bicuspid aortic valves 51 lung fibrosis 51 CALGB 51 prostate carcinogenesis 51 corneal ectasia 51 atherothrombotic 51 Gilles Montalescot 51 immuno suppressive 51 malignant pleural mesothelioma 51 figitumumab 51 darbepoetin alfa Aranesp 51 thrombocytosis 51 Budoff 51 serum leptin 51 anthracyclines taxanes 51 upper gastrointestinal bleeding 51 elevated CRP 51 Alessandro Riva 51 osteoid osteoma 51 Roger Perlmutter Amgen 51 Karl Skorecki 51 teratogens 51 Pepine 51 drug eluting stent implantation 51 nonfasting triglyceride levels 51 serum creatinine levels 51 androgen suppression 51 postoperative atrial fibrillation 51 papillary thyroid carcinoma 51 Hagop Kantarjian MD 51 cardiac toxicity 51 PROCHYMAL 51 Peritoneal Mesothelioma 51 Violari 51 ULORIC 51 Pantuck 51 univariate analyzes 51 Neurotoxicity 51 Coresh 51 Chronic pancreatitis 51 skeletal metastases 51 Pemphigus 51 doxorubicin Adriamycin 51 metastatic RCC 51 Xelox 51 Vidaver 51 acute renal 51 postoperative radiotherapy 51 microalbuminuria 51 Alfred I. Neugut 51 Squalamine 51 Legg Calvé Perthes disease 51 Initiative K DOQI 51 hypercholesterolaemia 51 prostate cancer CRPC 51 MD DMSc 51 haematologic malignancies 51 By Robert Preidt 51 incidentalomas 51 flecainide 51 Mayo Clinic Rochester MN 51 zoledronic acid Zometa 51 Dr. Eberhard Grube 51 lymphomas leukemias 51 imatinib resistance 51 hepatic function 51 Anders Sundstrom 51 valvular heart disease 51 Dahlof 51 STELARA ® 51 colon rectal cancer 51 George Coukos 51 Laffel 51 inhaled bronchodilators 51 lactate dehydrogenase LDH 51 Vogelzang MD 51 Serum creatinine 51 Abdul Ruff Colachal 51 aripiprazole Abilify 51 pCR 51 immunosuppressant drug 51 GnRH agonist 51 Erythropoietic therapies may 51 Dacogen decitabine 51 Glied 51 Narod 51 enoxaparin Lovenox 51 plasma renin activity 51 lipoprotein levels 51 TNFerade TM 51 Renal Insufficiency 51 atherogenic dyslipidemia 51 Quality Initiative KDOQI 51 moderate renal impairment 51 Mitomycin C 51 pamidronate 51 MD MSPH 51 thoracoscopic lobectomy 51 Gideon Koren 51 Interstitial cystitis 51 CDDO Im 51 intestinal permeability 51 Related Anemia 51 immune dysregulation 51 Zonszein 51 Acute Myeloid Leukaemia AML 51 MD MSc FRCPC 51 Noxafil 51 Arthur Schatzkin 51 Cryptococcus neoformans 51 Dialysis Outcomes 51 Parnate 51 #:#-# [023] 51 Lipoic acid 51 Knopman 51 Jellinger 51 AVASTIN 51 symptomatic carotid stenosis 51 diabetes dyslipidemia 51 rates Tangka 51 multiple sclerosis psoriasis 51 prostate carcinoma 51 symptomatic hyponatremia 51 Dahabreh 51 neuropathologic 51 triglyceride concentrations 51 pulmonary resection 51 ergotamine 51 H. pylori eradication 51 diabetic gastroparesis 51 NCEP guidelines 51 ACCOMPLISH 51 imatinib Gleevec 51 staphylococcal infection 51 Dr. Loprinzi 51 musculo skeletal pain 51 PhD tells WebMD 51 ADVEXIN therapy 51 cirrhosis liver failure 51 Acute myeloid leukemia 51 ischemic cardiac 51 Osteopenia 51 KRAS mutant tumors 51 corticosteroid therapy 51 Chapkin 51 carotid stenosis 51 bronchoalveolar 51 orlistat Xenical 51 Everolimus 51 familial pancreatic cancer 51 Kauffman MD Ph.D. 51 terazosin 51 prognostic variables 51 Dr. Roehrborn 51 Wilmanns 51 impair fertility 51 Kivipelto 51 allogeneic HSCT 51 Clauw 51 levodopa carbidopa 51 Melasma 51 monoclonal gammopathy 51 Teriparatide 51 McVary 51 isoflavone supplements 51 Chanan Khan 51 Primary endpoints 51 Consultant Rheumatologist 51 Tiganis 51 etanercept Enbrel 51 van der Steeg 51 Chemotherapy induced 51 postoperative AF 51 fibrate drugs 51 tryptase 51 QTc prolongation 51 Sjögren syndrome 51 Carvedilol 51 Nicholas Borys 51 Dr. Gambotto 51 tumor hypoxia 51 Pulmonologist 51 kidney urologic 51 carcinoid tumors 51 Marc Sabatine 51 digoxin toxicity 51 natriuresis 51 improves insulin sensitivity 51 Squamous Cell Carcinoma 51 concomitant medications 51 intracranial stenosis 51 Scarmeas 51 refractory acute myeloid 51 lumiracoxib 51 adrenal function 51 Piccart 51 adenomatous 51 steroid refractory 51 Mitoxantrone 51 Hepatocellular Carcinoma HCC 51 CVD mortality 51 tibolone 51 Tim Coughlin MAusIMM 51 inflammatory acne 51 metaplasia 51 Simos Simeonidis 51 Daviglus 51 invasive fungal 50 Karagas 50 Hormone pills 50 Rhinitis 50 cisplatin chemotherapy 50 RE LY 50 pemphigus vulgaris 50 pharmacokinetic interaction 50 JoAnn Manson chief 50 thymic carcinoma 50 Iris Shai 50 precursor lesions 50 antithrombotic therapy 50 neutropenic 50 causative pathogens 50 verteporfin 50 nesiritide 50 Ionizing Radiation 50 MD M.Sc. 50 bone marrow suppression 50 hormone deprivation 50 hibernating myocardium 50 Zeuzem 50 Mayo Clinic neurologist 50 intravascular hemolysis 50 perioperative morbidity 50 Matthew Meyerson 50 leukemia multiple myeloma 50 pulmonary metastases 50 NSAID induced 50 hyperoxaluria 50 postoperative morbidity 50 Tranexamic acid 50 Anthracycline 50 Shenassa 50 dyslipidaemia 50 McHutchison 50 Kuppermann 50 reflux disease GERD 50 Angioedema 50 chronic renal disease 50 dietary sodium 50 palivizumab 50 Setlow 50 ZOLINZA 50 Latuda 50 hepatic failure 50 Thromboembolic 50 overlapping toxicities 50 nonmelanoma skin cancers 50 neuropsychiatric adverse 50 shorter telomere length 50 Michael R. Harbut 50 Riluzole 50 silent myocardial ischemia 50 Inflammatory diseases 50 albuminuria 50 Ivabradine 50 Heterozygous Familial Hypercholesterolemia 50 gastrointestinal toxicity 50 malignant lymphomas 50 Acute Exacerbations 50 Genetic predisposition 50 Sc.M. 50 Tait Shanafelt MD 50 Stephanie Belloc 50 antiarrhythmic drugs 50 Neal Benowitz 50 Pleural Mesothelioma 50 Oreopoulos 50 Multivariate analysis 50 thyroxin 50 aldosterone antagonists 50 myocardial infarctions MIs 50 Lambris 50 Klesges 50 MD MHSc 50 induce remission 50 transcranial Doppler ultrasound 50 streptokinase 50 ADHF 50 Vulvar 50 type 1diabetes 50 Advanced Melanoma 50 Leibenluft 50 Sondak 50 NATRECOR R 50 epidural steroid injection 50 nondiabetic patients 50 Akathisia 50 Auchus 50 Decompensated 50 Helicobacter pylori eradication 50 thiopurine 50 gemifloxacin 50 ClearPath HDR 50 microvascular dysfunction 50 colorectal gastric 50 lowering blood glucose 50 Parnia 50 subclinical hyperthyroidism 50 SUTENT ® 50 lymph node removal 50 platelet inhibition 50 amifostine 50 nonallergic 50 By Karen Pallarito 50 J. Reinhard Cardium 50 plasma lipids 50 Rubenfire 50 Kandzari 50 tamoxifen raloxifene 50 interstitial pneumonia 50 University Hospital Gasthuisberg 50 Eisenmenger syndrome 50 Joseph Loscalzo 50 Primary Pulmonary Hypertension 50 vandetanib 50 Echocardiographic 50 biliary tract disease 50 peritoneal carcinomatosis 50 Jean Pierre Després 50 Ingrid van Heerden 50 breast carcinoma 50 sipuleucel T 50 Birmaher 50 colorectal adenomas 50 MGN# 50 chemosensitivity 50 membranous nephritis 50 Karl Swedberg 50 Shantha Rajaratnam 50 Singh Manoux 50 Routy 50 ezetimibe simvastatin 50 Okunieff 50 Vidofludimus 50 Arbiser 50 Kopans 50 adrenomedullin 50 valvulopathy 50 APPRAISE 50 ELACYT 50 eculizumab therapy 50 underlying pathophysiology 50 dual antiplatelet 50 cytomegalovirus infection 50 Glioma 50 Eric Van Cutsem 50 severe hypersensitivity reactions 50 ACEI 50 ADAGIO study 50 Cardiorespiratory fitness 50 nonpharmacologic 50 MD hematologist 50 Adenoma Prevention 50 Giuseppe Fortuni 50 Kalichman 50 T. Felson 50 dopaminergic therapy 50 sibutramine Meridia 50 troglitazone 50 radiation therapy SBRT 50 Losordo 50 Aggressive Reduction 50 STEP BD 50 neurologic progression 50 Dr. Vitetta 50 Ana Navas Acien 50 thromboembolic events 50 Perforomist ™ Inhalation Solution 50 spirometric 50 Maratos Flier 50 syncope fainting 50 oncologist hematologist 50 UA NSTEMI 50 CMV reactivation 50 Hypoglycaemia 50 atherosclerotic renal artery stenosis 50 prognostic indicators 50 intima media thickness 50 Polycythemia 50 Angela Genge 50 Eunyoung Cho 50 Frits Rosendaal 50 antigen PSA levels 50 Karen Mustian 50 Dr. Fehlings 50 Mylotarg 50 Dr. Eugene Braunwald 50 Prognostic Factors 50 acarbose 50 TMPRSS2 ERG fusion 50 immunopathology 50 NSAID induced gastrointestinal 50 parathyroidectomy 50 Polypharmacy 50 Biological Effects 50 Robert Hegele 50 ACOSOG Z# 50 Barbara Alving 50 coxibs